Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Carbon Dioxide for Nasal Congestion in Perennial Allergic Rhinitis
NCT00638755Phase 2Completed
- Sponsor
- Capnia, Inc.
- Start
- Feb 2008
- Primary completion
- May 2008
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Carbon dioxide in perennial allergic rhinitis (PAR), sponsored by Capnia, Inc.. Started Feb 2008; status: completed.
02
Drugs
Carbon dioxide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00638755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638755.